BODYCOTE PLC

BOY
Delayed Quote. Delayed  - 11/27 11:35:10 am
723GBX -0.34%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 720612
EBITDA1 210147
Operating profit (EBIT)1 13577,4
Operating Margin 18,7%12,6%
Pre-Tax Profit (EBT)1 12433,3
Net income1 93,827,3
Net margin 13,0%4,46%
EPS2 0,490,12
Dividend per Share2 0,200,16
Last update 03/12/202011/27/2020
1 GBP in Million
2 GBP
Estimates
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt1 58,5118
Net Cash position1 --
Leverage (Debt / EBITDA) 0,28x0,81x
Free Cash Flow1 99,663,8
ROE (Net Profit / Equities) 13,9%8,68%
Shareholders' equity1 674314
ROA (Net Profit / Asset) 9,54%5,71%
Assets1 984478
Book Value Per Share2 3,713,42
Cash Flow per Share2 0,930,40
Capex1 77,755,8
Capex / Sales 10,8%9,12%
Last update 03/12/202011/27/2020
1 GBP in Million
2 GBP
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 1 374 M GBP -
Entreprise Value (EV) 1 492 M GBP 1 502 M GBP
Valuation 2020e 2021e
P/E ratio (Price / EPS) 58,4x 19,1x
Capitalization / Revenue 2,24x 2,06x
EV / Revenue 2,44x 2,24x
EV / EBITDA 10,2x 8,10x
Yield (DPS / Price) 2,19% 2,81%
Price to book (Price / BVPS) 2,12x 2,10x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 12,6% 16,6%
Operating Leverage (Delta EBIT / Delta Sales) -2,86x 4,85x
Net Margin (Net Profit / Revenue) 4,46% 10,7%
ROA (Net Profit / Asset) 5,71% 8,37%
ROE (Net Profit / Equities) 8,68% 13,1%
Rate of Dividend 128% 53,7%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   9,12% 9,86%
Cash Flow / Sales 12,3% 17,0%
Capital Intensity (Assets / Sales) 0,78x 1,27x
Financial Leverage (Net Debt / EBITDA) 0,81x 0,69x
Price Earning Ratio
EPS & Dividend